The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the appointment of Mr. Sanjeev Kumar as the Chief Financial Officer and Key Managerial Personnel ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors approved multiple leadership changes at its May 19, 2026 meeting. Mr. Sanjeev Kumar has been appointed as Chief Financial Officer and Key Managerial Personnel effective May 25, 2026. He brings over 30 years of finance experience from Bharti Airtel, InterGlobe Enterprises, and Medanta – The Medicity, where he led the successful IPO of Global Health Ltd. Concurrently, Dr. Manish Mattoo, who was serving as Interim CFO in addition to his CEO role, will cease to hold the CFO position from the same date. Additionally, Mr. Rajiv Maliwal has been re-appointed as Non-Executive Independent Director for a second 5-year term, Mr. Ravi Gothwal appointed as AVP – Investor Relations (Senior Management), and Mr. Vijay S. Shanbhag re-appointed as Internal Auditor for one year.
The appointment of a dedicated, experienced CFO should bring stronger financial oversight and investor communication, particularly positive given Sanjeev Kumar's healthcare sector IPO experience. The CEO stepping down from interim CFO duties indicates better role segregation at the leadership level.